Mark Mallon
Chief Executive Officer at NeoGenomics Laboratories, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Douglas Van Oort | M | 68 |
NeoGenomics Laboratories, Inc.
 NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 15 years |
| Raymond R. Hipp | M | 81 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 13 years |
| Kevin Johnson | M | 69 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 14 years |
| Alexander Denner | M | 54 | 4 years | |
| Jay Shepard | M | 65 | 4 years | |
| Mark Currie | M | 69 | 4 years | |
| Robert Shovlin | M | 53 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 10 years |
| Catherine Moukheibir | F | 64 | 5 years | |
| Lynn Tetrault | F | 61 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 9 years |
| Marla Kessler | F | 54 | 5 years | |
| Jon Duane | M | 65 | 5 years | |
| Alison Hannah | M | 63 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 9 years |
| Shashikant Kulkarni | M | 57 | 2 years | |
| Charmaine Gittleson | M | - |
George Medicines UK Ltd.
 George Medicines UK Ltd. BiotechnologyHealth Technology George Medicines UK Ltd. is a company focused on late stage drug development to improve the management of non-communicable diseases. The company is based in London, UK. The British company does this by creating single-pill, multi-mechanism combinations of existing medicines. Stefan König has been the CEO of the company since 2021. | - |
| Karl Roberts | M | - |
George Medicines UK Ltd.
George Medicines UK Ltd. BiotechnologyHealth Technology George Medicines UK Ltd. is a company focused on late stage drug development to improve the management of non-communicable diseases. The company is based in London, UK. The British company does this by creating single-pill, multi-mechanism combinations of existing medicines. Stefan König has been the CEO of the company since 2021. | - |
| Hutan Hashemi | M | 45 | 2 years | |
| Ingmar Wahlqvist | M | - |
George Medicines UK Ltd.
George Medicines UK Ltd. BiotechnologyHealth Technology George Medicines UK Ltd. is a company focused on late stage drug development to improve the management of non-communicable diseases. The company is based in London, UK. The British company does this by creating single-pill, multi-mechanism combinations of existing medicines. Stefan König has been the CEO of the company since 2021. | - |
| Diane Stroehmann | F | 46 | 5 years | |
| Steven Ross | M | 60 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 11 years |
| Rachel Stahler | F | 48 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | - |
| Stephen Kanovsky | M | 61 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | - |
| Mustapha Bakali | M | 62 |
George Medicines UK Ltd.
George Medicines UK Ltd. BiotechnologyHealth Technology George Medicines UK Ltd. is a company focused on late stage drug development to improve the management of non-communicable diseases. The company is based in London, UK. The British company does this by creating single-pill, multi-mechanism combinations of existing medicines. Stefan König has been the CEO of the company since 2021. | - |
| Michael Kelly | M | 67 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 4 years |
| Bruce Crowther | M | 72 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 10 years |
| Derek Lyle | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Steven Jones | M | 59 |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | 18 years |
| Terry McGuire | M | 68 | 21 years | |
| Peter Hecht | M | 60 | 21 years | |
| Halley Gilbert | F | 54 | 12 years | |
| Marsha Fanucci | F | 70 | 10 years | |
| Kelly MacDonald | F | 40 | 8 years | |
| Amy Schulman | F | 63 | 2 years | |
| Douglas Williams | M | 66 | 5 years | |
| Denise Pedulla | F | 64 | 6 years | |
| David Daly | M | 62 | 2 years | |
| Conor Kilroy | M | - | - | |
| Cheryl Gault | F | 44 | 8 years | |
| Bertil Lindmark | M | 68 |
Astrazeneca Japan Ltd.
 Astrazeneca Japan Ltd. Medical/Nursing ServicesHealth Services Part of AstraZeneca PLC, Astrazeneca Japan Ltd. is a science-oriented bio and Japanese pharmaceutical company. The private company is based in Ofuka-cho, Japan. Astrazenka mainly focuses on oncology, cardiovascular, metabolism/gastrointestinal diseases, and respiratory diseases to further contribute to the development of patients' health and medical care. The CEO of the company is Stephen Voxstram. | 6 years |
| Lawrence Weiss | M | 67 | 6 years | |
| Stephanie Bywater | F | 53 | 4 years | |
| Jennifer M. Balliet | F | 46 | 14 years | |
| John Mooney | M | - | 2 years | |
| Stefan König | M | - |
George Medicines UK Ltd.
George Medicines UK Ltd. BiotechnologyHealth Technology George Medicines UK Ltd. is a company focused on late stage drug development to improve the management of non-communicable diseases. The company is based in London, UK. The British company does this by creating single-pill, multi-mechanism combinations of existing medicines. Stefan König has been the CEO of the company since 2021. | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 37 | 86.05% |
| United Kingdom | 5 | 11.63% |
| Japan | 1 | 2.33% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark Mallon
- Personal Network